Daejeon, South Korea

Yu Jin Lee

This inventor holds 1 USPTO granted patent and 23 published patent applications, plus 1 CIPO patent. Top assignee: Vspharmtech. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Jin Lee. Retrieved from https://idiyas.com/inventor/yu-jin-lee-zzsuqgha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Jin Lee: Innovator in Cancer Metastasis Treatment

Introduction

Yu Jin Lee is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of cancer research, particularly in the area of cancer metastasis. Her innovative work focuses on developing pharmaceutical compositions that can prevent or treat cancer metastasis.

Latest Patents

Yu Jin Lee holds a patent for "Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells." This invention relates to a pharmaceutical composition designed to prevent or treat cancer metastasis. It includes a novel compound that inhibits the migration and invasion of cancer cells, or a pharmaceutically acceptable salt thereof, as an active ingredient.

Career Highlights

Yu Jin Lee is currently associated with Vspharmtech, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and patient outcomes.

Collaborations

She collaborates with notable colleagues, including Byoung-Mog Kwon and Dong Cho Han, who contribute to her research initiatives.

Conclusion

Yu Jin Lee's innovative approach to cancer treatment through her patented inventions highlights her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…